Live WebinarAn overview of the current diagnostic & therapy according to the Würzburg concept – From prophylaxis up to restoration
01 Oct 2020, 01:00 AM Shanghai
Prof. Dr. Norbert Krämer, Katrin Bekes MME
The new R & D centre was built with an investment of over €63 million and opened on 30 July. Together with the current manufacturing centre, the Orange Tower in Busan, it will function as the R & D centre as well as the global corporate headquarters of Osstem Implant. With the new global R & D centre, the company now has its full infrastructure all in one venue in order to enhance R & D, as well as improve collaboration between other departments such as quality regulation, licensing, marketing and administration. The new R & D centre will contribute towards achieving Osstem Implant’s vision of becoming the leader in the global dental implant industry by 2023. It is expected to be a next-generation dental complex that incorporates the latest technologies.
Osstem Implant has been consistently developing R & D as the key to its competitiveness. “As research is the core element of the company, we are investing over 7% of sales revenue in R & D annually,” said Dr Tae-Kwan Eom, CEO of Osstem Implant. At the new R & D centre, the company will bring together researchers from its ten other research centres and hire over 500 additional experienced researchers. On 31 July, Osstem Implant was listed among this year’s 100 best companies to work for by the South Korean Ministry of Employment and Labor.
Osstem Implant has been striving to enhance the clinical implant knowledge and treatment capabilities of dentists. The company has invited over 12,000 South Korean dentists and 1,000 dentists from other countries around the globe to undergo in-depth clinical training and education at the new site.